Expert Interviews

Dr. Samilia Obeng-GyasiBreast Cancer | April 1, 2024
Dr. Samilia Obeng-Gyasi discusses how social factors can impact outcomes in breast cancer patients.
View More
Stacy StephensAI | March 28, 2024
Stacy Stephens explains how autonomous security robots are boosting surveillance and communication in hospitals.
Arun KrishnaNon-Small Cell Lung Cancer | April 4, 2024
Arun Krishna, of AstraZeneca, talks about the phase 3 FLAURA2 trial, which assessed Tagrisso in patients with NSCLC.
Shubham Pant, MD, MBBSPancreatic Cancer | March 15, 2024
Dr. Pant discusses the relationship between T cell response magnitude and tumor biomarker reduction.
Michael SpiglerVideos | March 15, 2024
Michael Spigler presents highlights of the American Kidney Fund's fifth annual Kidney Action Week.
Patrick DalyPNH | March 14, 2024
Dr. Griffin shares data from their real-world study on pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria.
Patrick DalyPolycythemia Vera | March 1, 2024
Dr. Grunwald of the Atrium Health Levine Cancer Institute, discusses caring for patients with PV on rare disease day.
Dr. Bob WalkerHypertension | February 29, 2024
Dr. Bob Walker discusses high blood pressure in the context of severe COVID-19 infection.
Gabriel Brooks, MDGI Cancer | February 27, 2024
Dr. Brooks explains the association between male sex and 5-FU exposure.
Zahra Pakbaz, MDSickle Cell Disease | February 27, 2024
Dr. Pakbaz describes some of the difficulties faced by patients with SCD as they switch from pediatric to adult programs.
Marisa Bittoni, PhDLung Cancer | February 22, 2024
Marisa Bittoni, PhD, talks about a large-scale study exploring factors that lead to lung cancer in patients younger than 50.
Cynthia Miller, MDLipid Management | February 21, 2024
Cynthia Miller, MD, MPH, FACP, discusses why early Lp(a) screening may help prevent cardiovascular disease.
Patrick DalySickle Cell Disease | February 13, 2024
Drs. Grant, Sutin, and Lin discuss their pilot study investigating cerebral hemodynamics in infants with sickle cell disease.
Pavlos Msaouel, MD, PhDOncology | February 12, 2024
What does the data and overall understanding of VEGF-TKIs tell us about which patients are optimal candidates for tivozanib?
John Strouse, MD, PhDSickle Cell Disease | March 19, 2024
Dr. Pakbaz and Dr. Strouse discuss their experiences practicing classical hematology and where the speciality is heading.
Patrick DalySickle Cell Disease | February 8, 2024
Dr. Pakbaz, from the University of California Irvine, shared data on the value of a dedicated classical hematology clinic.
Dr. Mark BleackleyRheumatology | February 2, 2024
Incannex announces the first dosing in a phase 2 study of a novel drug combination comprising HCQ and CBD to treat RA.
Ashley GainesBreast Cancer | January 18, 2024
The FDA recently approved a new combination therapy for the treatment of HR-positive, HER2-negative breast cancer.
Patrick DalyMyelofibrosis | February 16, 2024
Dr. Hobbs shared findings supporting the safety and feasibility of continuing ruxolitinib during and after HSCT for MF.
Christopher Lieu, MDASCO GI 2024 | January 23, 2024
Dr. Christopher Lieu gives an overview of some of the top presentations and data to look out for at ASCO GI 2024.
Dr. Richard LafayetteChronic Kidney Disease | February 5, 2024
Dr. Richard Lafayette discusses the FDA approval of TARPEYO, which reduces the loss of kidney function in IgA nephropathy.
Latest News

April 12, 2024